Mohlo by se vám také líbit

Více informací o knize Breakthrough Business Models

• Parametry knihy
• Anotace
• Oblíbené z jiného soudku

Nákupem získáte 121 bodů

Anotace knihy

The process for developing new drug and biologic products is extraordinarily expensive and time-consuming. Although large pharmaceutical companies may be able to afford the cost of development because they can expect a large return on investment, organizations developing drugs to treat rare and neglected diseases are unable to rely on such returns. On June 23, 2008, the Institute of Medicine's Forum on Drug Discovery, Development, and Translation held a public workshop, "Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies," which sought to explore new and innovative strategies for developing drugs for rare and neglected diseases.

Parametry knihy

Zařazení knihy Knihy v angličtině Medicine

• Plný název: Breakthrough Business Models
• Podnázev: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary
• Autor: Theresa Wizeman, Sally Robinson, Robert Giffin, Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of M
• Jazyk: Angličtina
• Vazba: Brožovaná
• Počet stran: 150
• EAN: 9780309120883
• ISBN: 0309120888
• ID: 04578822
• Nakladatelství: National Academies Press
• Hmotnost: 249 g
• Rozměry: 229 × 152 × 10 mm
• Datum vydání: 31. December 2008

Oblíbené z jiného soudku

---

---

---